Review Article

Toxicological Effects of Titanium Dioxide Nanoparticles: A Review of In Vivo Studies

Table 1

In vivo studies that investigated the adverse effects of TiO2 NPs on respiratory system.

Respiratory system
ReferencesCrystal phase composition (particle size in nm)Type of exposureType and number of animalsResults

Takenaka et al., 1986 [52]Anatase TiO2 (15–40)Inhalation: aerosols of 8.6 mg/m3 TiO2 for 7 hr/day, 5 day/wk for up to 1 year.24 female Wistar ratsLung burden: TiO2 was found in macrophages and in the perivascular spaces.

Ferin et al., 1992 [53]Rutile TiO2 (12; 230)
Anatase TiO2 (21; 250)
Intratracheal instillation: all TiO2: 500 μg; 21 nm TiO2: 65–1000 μg/rat; 250 nm TiO2: 1000 μg/rat.
Inhalation: 2 3 . 5 ± 3 . 2  mg/m3 21 nm TiO2; 2 3 . 0 ± 4 . 1  mg/m3 250 nm TiO2 for 6 h/day, 5 day/wk for up to 12 wks.
Instillation study: 4–8 male Fischer 344 rats
Inhalation study: 4 male Fischer 344 rats per group.
Instillation study: unlavagable lung burden decreased from 12 nm to 250 nm particles.
Inhalation study: greater 21 nm TiO2 NP concentration in the interstitium, epithelial cells, and alveolar space.

Basic intratracheal instillation: 500 μg of 250 and 20 nm TiO2.Basic instillation: 4 male Fischer 344 rats per group.Basic instillation: higher lung retained amount and greater inflammatory response in the 20 nm TiO2 NP treatment.
Oberdorster et al., 1992 [54]Anatase TiO2 (~20; ~250)
Rutile TiO2 (~12; ~220)
Intratracheal reinstillation: 1 0 4 ± 8 μg 20 nm free TiO2, 1 0 4 ± 1 0 μg, 20 nm TiO2 phagocitized by AMs, 100 μg serum coated particles, 6 . 8 × 1 0 6  AMs, 2 . 2 × 1 0 6  PMNs.Reinstillation: 4–10 male Fischer 344 rats per group.Reinstillation: greater amount of free particles retained in lavaged lungs.
Intratracheal dose-response: 500, 1000 μg 250 nm TiO2; 65–1000 μg 20 nm TiO2; 500 μg 220 nm TiO2; 500 μg 12 nm TiO2.Dose-response: 20 nm TiO2 NPs caused a dose-dependent PMN lung influx.

Oberdorster et al., 1994 [55]Anatase TiO2 (20; 250)Inhalation: aerosols of 2 3 . 5 ± 2 . 9  mg/m3 20 nm TiO2 and 2 2 . 3 ± 4 . 2  mg/m3 250 nm TiO2 for 6 hr/day, 5 day/wk for up to 12 wks.64 male Fischer 344 ratsInflammatory action: AMs, PMNs, TPC increased in BAL.
Pulmonary retention: increased after 20 nm TiO2.
Histology: lung fibrosis after 20 nm TiO2.

Heinreich et al., 1995 [56]P25 Degussa TiO2 (15–40)Inhalation: 10 mg/m3 TiO2 for 18 hr a day for 24 (rats) and 13.5 (mice) months.100 female Wistar rats 80 NMRI miceRats: adenocarcinomas, squamous cell carcinomas, adenomas increased.
Mice: no differences in tumor rates.

Baggs et al., 1997 [57]Pigment-grade TiO2 (250)
Degussa TiO2 (20)
Inhalation: aerosols of 22.3 mg/m3 of 250 nm TiO2 and 23.5 mg/m3 of 20 nm TiO2 for 6 hr/day, 5 day/wk for up to 12 wks.3-4 male Fischer 344 rats per groupHistology: alveolar epithelial thickness and septal fibrosis after both TiO2 treatments.

Zhang et al., 1998 [58]TiO2 (28)Intratracheal instillation: 1 mg TiO2.4–6 male Wistar rats per groupInflammatory action: TCC, NEUs, AMs, TPC, and LDH increased in BAL.

Afaq et al., 1998 [59]TiO2 (30)Intratracheal instillation: 2 mg TiO2 per animal.6 female Albino rats per groupInflammatory action: AMs, ACP, and LDH increased in BAL.
Oxidative stress: LPO and antioxidant activities increased

Oberdorster et al., 2000 [60]TiO2 (20; 250)Intratracheal instillation: no more detailedRats MiceInflammatory action: NEUs increased after 20 nm TiO2.

Höhr et al., 2002 [61]Native or methylated TiO2 (20–30; 180)Intratracheal instillation: equivalent mass (1 or 6 mg) and surface doses (100, 500, 600 and 3000 cm2) of TiO2 per animal.5 female Wistar rats per groupInflammatory action: native TiO2 NPs increased TCC, PMNs, TPC, ALP, LDH, GGT, NAG and β glucuronidase in BAL.

Bermudez et al., 2004 [49]P25 Degussa TiO2 (21)Inhalation: aerosols of 0.5–10 mg/m3 TiO2 for 6 hr/day, 5 days/week, for 13 weeks.Groups of 25 animals for each species: Female 3C3F1/CrlBR mice; CDF (F344)/CrlBR rats; Lak:LVG (SYR) BR hamsters.Lung burdens: equivalent in rats and mice, lower in hamsters.
Inflammatory action: increase in TCC, AMs, NEUs, LYMs (rats and mice); TPC and LDH in BAL (rats); only NEUs in hamsters;
Histology: terminal bronchiolar and alveolar cell replication.

Renwick et al., 2004 [62]TiO2 (29; 250)Intratracheal instillation: 125, 500 μg TiO2.Male Wistar ratsInflammatory action: NEUs, GGT, TPC, LDH increased after 29 nm TiO2 in BAL.
AM phagocytotic ability: decreased.

Warheit et al., 2006 [39]Rutile pigment grade TiO2 (300)
Anatase TiO2 rods (length: 92–233; wide: 20–35)
Anatase TiO2 dots (5.8–6.1)
Intratracheal instillation: 1, 5 mg/kg TiO2.5 male Crl:CD(SD)IGS BR rats per groupInflammatory action: increase in NEUs (all particles) and LDH (TiO2 rods).
Histology: TiO2-containing aggregated macrophages in lung (all particles).

Warheit et al., 2007 [44, 45]~98% rutile TiO2, 2% alumina (~100)
~88 wt% rutile TiO2, ~7 wt% amorphous silica, ~5 wt% alumina (~100)
P25 Degussa TiO2 (~25)
~99% rutile TiO2, ~1% alumina (382 in water)
Intratrachel instillation: 1, 5 mg/kg TiO2.4-5 male Crl:CD(SD)IGS BR rats per groupInflammatory action: NEUs, LDH, and microprotein increased in BAL by P25 TiO2
Cell proliferation: airway and lung parenchymal cells proliferation increased after P25 TiO2.
Histology: AM accumulation with tissue thickening after P25 TiO2.

Chen et al., 2006 [42]Rutile TiO2 (21)
TiO2 (180–250)
Intratracheal instillation: 0.1, 0.5 mg TiO2.6 male ICR mice per groupLung morphology: emphysematous change and alveolar epithelial thickness after 21 nm TiO2 NPs.
Apoptosis: increased in AMs and PNEs.

Grassian et al., 2007 [41]Anatase TiO2 (3.5 ± 1.0)Inhalation: aerosols of 0.77, 7.22 mg/m3 TiO2 for 4 hr (acute exposure); and 8 . 8 8 ± 1 . 9 8  mg/m3 TiO2 for 4 hr/day for 10 days (subacute exposure).6 male C57Bl/6 mice per groupAcute exposure: TCC and AMs increased in BAL.
Subacute exposure: AMs increased in BAL.

Li et al., 2007 [35]Anatase TiO2 (3)
TiO2 (20)
Intratracheal instillation: 0.4–40 mg/kg TiO2.5 Male Kunming mice per groupBAL biochemical parameters: TPC, ALB, ALP, and ACP increased by both TiO2.
Histology: alveolar wall thickening and destruction.

Geiser et al., 2005 [63]TiO2 (4)Inhalation: 10 rats were exposed to 0.11 mg/m3 TiO2 aerosols for 1 hr.10 male WKY/NCrl BR ratsTiO2 distribution: luminal side of airways/alveoli (79.3%), epithelial or endothelial cells (4.6%), connective tissue (4.8%), capillaries (11.3%).

Mühlfeld et al., 2007 [64]See Geiser et al., 2005 [63]TiO2 distribution: connective tissue and the capillary lumen were the preferential target of NPs at 1 and 24 hr, respectively.

Nemmar et al., 2008 [43]Rutile TiO2 nanorods (4–6)Intratracheal instillation: 1, 5 mg/kg TiO26-7 male Wistar rats per groupInflammatory action: AMs, PMNs increased in BAL.
Tissue injury: edema in lung and heart.

Larsen et al., 2010 [65]TiO2 (28)Intraperitoneal injections: immunization with 1 μg OVA alone or in combination with either 2, 10, 50 or 250 μg TiO2.7-8 inbred female BALB/cJ mice per groupOVA-specific antibodies in serum: TiO2 increased IgE and IgG1 levels compared to the OVA-controls.
Inflammatory action: EOSs, NEUs, LYMs, IL-4, and IL-5 increased in BAL.

Hamilton et al., 2009 [37]Anatase TiO2 nanospheres (60 ~ 200)
Anatase TiO2 long nanobelts (width: 60 ~ 300 nm; length 15 ~ 30 nm)
Anatase TiO2 short nanobelts (width: 60 ~ 300; length 0.8–4 μm)
Pharyngeal aspiration: 30 μg/mouse TiO2.Male C57BL/6 miceInflammatory action: cathepsins, IL-1β, IL-18 increased after long nanobelts aspiration.

Kobayashi et al., 2009 [38]Anatase TiO2 (4.9) (1st and 2nd experiment)
Anatase TiO2 (23.4)
Anatase TiO2 (154.2)
Intratracheal instillation: 5 mg/kg TiO2.5 male Crl: CD (SD) rats per groupInflammatory action:
1st: 4.9 and 23.4 nm TiO2 NPs increased TCC, NEUs, LDH;
2nd: agglomerated TiO2 increased TCC, NEUs, LDH.
Histology: epithelium hypertrophy in all treated groups.

Van Ravenzwaay et al., 2009 [66]Anatase-rutile TiO2 mixture (20–30)
Rutile TiO2 (200)
Inhalation: aerosols of 100 and 250 mg/m3 uncoated and pigmentary TiO2, respectively for 6 h/day on 5 consecutive days.
Intravenous injections: 5 mg/kg.
3–6 male Wistar rats (strain Crl:WI (Han) per groupTiO2 distribution: lung and mediastinal lymph node after inhalation; mostly liver and spleen after injection.
Inflammatory action: both TiO2 increased TCC, PMNs, TPC, ALP, LDH, GGT, NAG in BAL.

Ma-Hock et al., 2009 [67]Rutile-anatase TiO2 mixture (25.1)Inhalation: aerosols of 2–50 mg/m3 TiO2 for 6 hr/day for 5 days.5-6 male Wistar rats (strain Crl: WI (Han)) per groupInflammatory action: PMNs, GGT, TPC, LDH, ALP, NAG increased in BAL.
Cell replication: increased in bronchi and bronchioles.

Liu et al., 2009 [36]Anatase TiO2 (5)
P25 Degussa TiO2 (21)
Rutile TiO2 (50)
Intratracheal instillation: 0.5–50 mg/kg.12 male and female Sprague Dawley rats per groupInflammatory action: LDH and ALP increased in lung by 5 and 50 nm TiO2.
Histology: inflammatory infiltration, alveolar wall thickening.
AM phagocytic ability: altered by 5 and 50 nm TiO2.

Sager et al., 2008 [12]P25 TiO2 (21)
Rutile TiO2 (1 μm)
Intratracheal instillation: 0.26–1.04 mg/rat for 21 nm TiO2 and 5.35–21.41 mg/rat for 1 μm TiO2.Male Fischer CDF (F344/DuCrl) ratsInflammatory action: both TiO2 increased PMNs, LDH, ALB, TNFα, IL-1β, MIP2.
Oxidative stress: increased by both TiO2.

Sager and Castranova, 2009 [68]P25 TiO2 (21)Intratracheal instillation: 0.26–1.04 mg/rat TiO2.8 male Fischer CDF (F344/DuCrl) rats per groupInflammatory action: increase in PMNs, ALB, and LDH in BAL.

Park et al., 2009 [69]P25 TiO2 (21)Intratracheal instillation: 5, 20, 50 mg/kg TiO2.10–12 ICR mice per groupInflammatory action: IL-1, TNF-α, IL-6, IL-12, IFN-γ, IL4, IL-5, IL-10, and IgE increased in BAL.
Histology: inflammatory proteins, granulomas.
Gene expression: upregulation of genes involved in antigen presentation and immune cell chemotaxis.

Chen et al., 2009 [22]Anatase TiO2 (80–110)Intraperitoneal injections: 324–2592 mg/kg TiO2.10 male and female ICR mice per groupHistology: alveolar septal thickening and interstitial pneumonia.

Moon et al., 2010 [47]P25 TiO2 (21)Intraperitoneal injections: 40 mg/kg TiO2 alone or 30 min after 5 mg/kg LPS injection.10 BALB/c mice per groupInflammatory action: NEUs, TPC; TNF-α, IL-1β, MIP2 increased by TiO2 or TiO2 + LPS.

Rossi et al., 2010 [70]Rutile TiO2 (<5 μm)
Rutile-anatase TiO2 mixture (30–40)
Anatase TiO2 (<25)
Silica coated rutile TiO2 (~ 1 0 × 4 0 )
Anatase TiO2/brookite (21)
Inhalation: 1 0 ± 2  mg/m3 TiO2 for 2 hr; 2 hr on 4 consecutive days; 2 hr on 4 consecutive days for 4 wks.8 female BALB/c/Sca mice per groupInflammatory action: NEUs in BAL, CXCL1 lung tissue, TNF-α in AMs increased by silica TiO2.

Rossi et al., 2010 [71]Silica coated rutile TiO2 (~10 × 40)
Rutile TiO2 (<5 μm)
Inhalation: 1 0 ± 2  mg/m3 TiO2 for 2 hr a day, 3 days a wk, for 4 wks.8 female BALB/c/Sca mice per groupInflammatory action: EOSs, LYMs, AMs, PAS+ globet cells, IL-1β, TNF-α, IL-4, -13, -10 decreased by silica TiO2.
Airway reactivity: decreased by silica TiO2; increased by fine TiO2

Scuri et al., 2010 [72]P25 Degussa TiO2 (21)Inhalation: 12 mg/m3 TiO2 for 5.6 hr a day, for 3 consecutive days.29 male and female Fischer 344 ratsNeurotrophin expression: NGF, BDNF and their receptors increased in 2 day and 2 wk old rats.
Airway resistance: increased in 2 wk old mice.

Li et al., 2010 [73]Anatase TiO2 (3)Intratracheal instillation: 3.3 mg/kg TiO2 once a wk for 4 wks.13 male Kunming mice per groupInflammatory action: ACP, ALP increased in BAL.
Histology: destroyed alveolar walls.

Liu et al., 2010 [74]TiO2 (5)
TiO2 (200)
Intratracheal instillation: 0.5–50 mg/kg TiO23 male and 3 female Sprague-Dawley rats per groupAM phagocytic and chemotactic ability: reduced by TiO2 NPs.

Tang et al., 2010 [75]TiO2 (5)Intratracheal instillation: 0.8–20 mg/kg TiO2.8 male Sprague Dawley rats per groupTiO2 NP aggregation: present in lung at the lowest doses.
Histology: lung gaps expanded, hyperemia

Tang et al., 2011 [40]Anatase TiO2 (5±1)Intratracheal instillation: 0.8–20 mg/kg TiO2.8 male Sprague Dawley rats per groupHistology: AM increase, lung gaps expanded, hyperemia, alveolar thickness.

Cho et al., 2010 [32]TiO2 (30–40)Intratracheal instillation: 50 and 150 cm2/rat5 female Wistar rats per groupInflammatory action in BAL and histology of the lung: no effect.

Leppanen et al., 2011 [76]Anatase + Brookite TiO2 (20 nm)Inhalation: 830 mg/m3 for 0.5 hr (acute exposure); 30 mg/m3 for 1 hr a day, 4 days a wk for 4 wks (sub-chronic exposure)4–6 male Crl:OF1 mice per groupAirflow limitation effect: reduction in expiratory flow in all the exposure situations.
Inflammatory action: no effect

Morimoto et al., 2011 [46]Rutile TiO2 (35)Inhalation: 2 . 8 ± 0 . 9 × 1 0 5 /cm3 6 hr a day for 4 wks.30 male Wistar rats per groupInflammatory action: no effect.

Hougaard et al., 2010 [77]Rutile UV-titan L181, modified with Zr, Si, Al and coated with polyalcohols ( 2 0 . 6 ± 0 . 3 )Inhalation: 4 2 . 4 ± 2 . 9 TiO2 mg/m3 for 1 hr a day, for 11 gestational consecutive days.Female time-mated C57BL/6BomTac miceInflammatory action: increased NEUs, and LYMs, decreased AMs in BAL.

Halappanavar et al., 2011 [78]See Hougaard et al., 2010 [77]Inflammatory action: TiO2 increased mRNA for Saa1, Saa3, several C-X-C and C-C motif chemokines, TNF-α.

Nemmar et al., 2011 [79]Rutile Fe-doped nanorod TiO2 (length: 80; diameter: 7)Intratracheal instillation: 1,5 mg/kg TiO24 male Wistar rats per groupInflammatory action: NEUs, IL-6 increased, SOD activity decreased in BAL.
Histology: inflammatory cell infiltration.

Hussain et al., 2011 [80]Anatase TiO2 (15)Oropharyngeal aspiration: ~0.8 mg/kg TiO25-6 male BALB/c miceAirway reactivity: increased by TiO2 in TDI sensitized mice
Inflammatory action: TiO2 increased NEUs and AMs in BAL of TDI sensitized mice.

Gustafsson et al., 2011 [48]P25 Degussa TiO2Intratracheal instillation: 1, 5, and 7.5 mg/kg TiO25–20 male Dark Agouti rats per groupInflammatory action: transient increase in EOSs and NEUs in BAL, followed by a recruitment of DCs and NKs. Elevated levels of IL-1, IL-2, IL-6, CINC-1, and GM-CSF.

ACP, acid phosphatase; ALB, albumin; ALP, alkaline phosphatase; AM, alveolar macrophage; BAL, bronchoalveolar lavage; BDNF, brain-derived neurotrophic factor; CINC-1, cytokine induced neutrophil chemoattractant-1; CXCL-1, chemokine (C-X-C motif) ligand 1; DC, dendritic cell; NK, natural killer; EOS, eosinophil; GGT, γ-glutamyl transpeptidase; GM-CSF, granulocyte-macrophage colony-stimulating factor; Ig, immunoglobulin; IL-, interleukin; IFN-γ, interferon-γ; LDH, lactate dehydrogenase; LPO, lipid peroxidation; LPS, lipopolysaccharide; LYM, lymphocyte; MIP-2, macrophage-inflammatory protein-2; NAG, N-acetyl-glucosaminidase; NEU, neutrophil; NGF, nerve growth factor; PAS, Periodic Acid-Schiff; PMN, polymorphonuclear; PNE, pneumocyte; Saa, serum amyloid A-; SOD, superoxide dismutase; TiO2 NPs, titanium dioxide nanoparticles; TCC, total cell count; TDI, toluene diisocyanate; TNF-α, tumor necrosis factor-α; TPC, total protein content.